Adicet Bio Statistics
Share Statistics
Adicet Bio has 82.40M shares outstanding. The number of shares has increased by 0.3% in one year.
| Shares Outstanding | 82.40M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 66.21M |
| Failed to Deliver (FTD) Shares | 559 |
| FTD / Avg. Volume | 0.1% |
Short Selling Information
The latest short interest is 3.43M, so 4.16% of the outstanding shares have been sold short.
| Short Interest | 3.43M |
| Short % of Shares Out | 4.16% |
| Short % of Float | 5.18% |
| Short Ratio (days to cover) | 7.04 |
Valuation Ratios
The PE ratio is -0.57 and the forward PE ratio is -0.9.
| PE Ratio | -0.57 |
| Forward PE | -0.9 |
| PS Ratio | 0 |
| Forward PS | 28.2 |
| PB Ratio | 0.48 |
| P/FCF Ratio | -0.83 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Adicet Bio Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.41, with a Debt / Equity ratio of 0.
| Current Ratio | 8.41 |
| Quick Ratio | 8.41 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.84% and return on capital (ROIC) is -79.56%.
| Return on Equity (ROE) | -0.84% |
| Return on Assets (ROA) | -0.69% |
| Return on Capital (ROIC) | -79.56% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -997.61K |
| Employee Count | 143 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -59.5% in the last 52 weeks. The beta is 1.7, so Adicet Bio 's price volatility has been higher than the market average.
| Beta | 1.7 |
| 52-Week Price Change | -59.5% |
| 50-Day Moving Average | 1.09 |
| 200-Day Moving Average | 1.44 |
| Relative Strength Index (RSI) | 49.95 |
| Average Volume (20 Days) | 543.50K |
Income Statement
| Revenue | n/a |
| Gross Profit | -6.10M |
| Operating Income | -152.04M |
| Net Income | -142.66M |
| EBITDA | -136.53M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -3.31 |
Balance Sheet
The company has 159.71M in cash and 20.92M in debt, giving a net cash position of 138.79M.
| Cash & Cash Equivalents | 159.71M |
| Total Debt | 20.92M |
| Net Cash | 138.79M |
| Retained Earnings | -380.77M |
| Total Assets | 245.96M |
| Working Capital | 186.92M |
Cash Flow
In the last 12 months, operating cash flow was -93.72M and capital expenditures -4.46M, giving a free cash flow of -98.18M.
| Operating Cash Flow | -93.72M |
| Capital Expenditures | -4.46M |
| Free Cash Flow | -98.18M |
| FCF Per Share | -2.28 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACET does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -337.76% |
| FCF Yield | -121.96% |
Analyst Forecast
The average price target for ACET is $5, which is 410.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $5 |
| Price Target Difference | 410.2% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Sep 16, 2020. It was a backward split with a ratio of 1:7.
| Last Split Date | Sep 16, 2020 |
| Split Type | backward |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | -1.97 |
| Piotroski F-Score | 3 |